Nappy dermatitis — branching viva

Branching framework

Open with the one-sentence problem representation. This is a candidal nappy dermatitis in a nine-month-old boy, precipitated by the recent amoxicillin course, superimposed on an irritant base. The decisive features are the involvement of the inguinal folds — which the irritant subtype spares — and the satellite papules at the edge, which are the pathognomonic feature of the candidal subtype. State the recognition aloud — the folds involved, the satellites present, the recent antibiotic course — before you discuss the management. The examiner is listening for whether you separate the subtypes at the bedside before you reach for the treatment. ^{[1] [3]}

Name the bedside distinction and the pathophysiology. The irritant subtype spares the folds because they are the skin least exposed to the urine and the faeces, and the candidal subtype involves them because the warm, moist, occluded fold is the environment where Candida thrives. The pathophysiology of the irritant subtype is the disruption of the stratum corneum by the moisture, the faecal enzymes, and the elevated pH under the occluded nappy, and the candidal subtype is the opportunistic overgrowth of Candida albicans on the disrupted skin. Be ready for the probe on the ammonia: the urease-producing organisms convert the urea to ammonia, raising the skin pH and activating the faecal proteases and lipases that digest the corneocyte barrier. ^{[1] [3]}

Branch to the management sequence. The management is the general skin care, the barrier preparation, and the antifungal. The nappy is changed every two to three hours and after every stool, the super-absorbent disposable nappy is used, the skin is cleansed with the warm water and the soft cloth — not the alcohol wipe — and the air exposure is encouraged. The zinc oxide paste at fifteen to forty percent or the petrolatum is applied generously at every change, and the old layer is gently wiped and not scrubbed off. The antifungal — the clotrimazole 1 percent or the miconazole 2 percent cream, twice daily for ten to fourteen days — is applied to the affected skin before the barrier layer. The hydrocortisone 1 percent, once or twice daily for three to five days, is added if the inflammation is intense, and the potent steroids are avoided because the occlusion increases the absorption and the atrophy risk. ^{[5] [4]}